ZA200608832B - Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof - Google Patents

Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof Download PDF

Info

Publication number: ZA200608832B
Authority: ZA; South Africa
Prior art keywords: alkyl; alkylene; hydrogen; replaced; phenyl
Prior art date: 2004-06-11

Application number

ZA200608832A

Other languages

English (en)

Inventor

Brummerhop Harm

Glombik Heiner

Bickel Martin

Theis Stefan

Frick Wendelin

Plettenburg Oliver

Heuer Hubert

Original Assignee

Sanofi Aventis Deutschland

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-11

Filing date

2006-10-24

Publication date

2008-05-28

2006-10-24 Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland

2008-05-28 Publication of ZA200608832B publication Critical patent/ZA200608832B/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Diabetes (AREA)
Hematology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Obesity (AREA)
Rheumatology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Urology & Nephrology (AREA)
Psychiatry (AREA)
Biotechnology (AREA)
Pulmonology (AREA)
Orthopedic Medicine & Surgery (AREA)
Virology (AREA)
Genetics & Genomics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Hospice & Palliative Care (AREA)
Dermatology (AREA)
Vascular Medicine (AREA)
Tropical Medicine & Parasitology (AREA)
Endocrinology (AREA)

ZA200608832A 2004-06-11 2006-10-24 Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof ZA200608832B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE102004028241A DE102004028241B4 (de)	2004-06-11	2004-06-11	Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel

Publications (1)

Publication Number	Publication Date
ZA200608832B true ZA200608832B (en)	2008-05-28

Family

ID=35355753

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200608832A ZA200608832B (en)	2004-06-11	2006-10-24	Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof

Country Status (34)

Country	Link
US (1)	US7820804B2 (ru)
EP (1)	EP1758914B1 (ru)
JP (1)	JP4996464B2 (ru)
CN (1)	CN100582116C (ru)
AR (1)	AR049393A1 (ru)
AU (1)	AU2005252329B2 (ru)
BR (1)	BRPI0510770A (ru)
CA (1)	CA2570042C (ru)
CR (1)	CR8773A (ru)
CY (1)	CY1107426T1 (ru)
DE (2)	DE102004028241B4 (ru)
DK (1)	DK1758914T3 (ru)
EC (1)	ECSP067054A (ru)
ES (1)	ES2296180T3 (ru)
HK (1)	HK1100411A1 (ru)
HR (1)	HRP20080023T3 (ru)
IL (1)	IL179757A (ru)
MA (1)	MA28653B1 (ru)
MX (1)	MXPA06013513A (ru)
MY (1)	MY143565A (ru)
NO (1)	NO20070176L (ru)
NZ (1)	NZ551948A (ru)
PE (1)	PE20060297A1 (ru)
PL (1)	PL1758914T3 (ru)
PT (1)	PT1758914E (ru)
RS (1)	RS50541B (ru)
RU (1)	RU2370499C2 (ru)
SI (1)	SI1758914T1 (ru)
TN (1)	TNSN06409A1 (ru)
TW (1)	TWI382030B (ru)
UA (1)	UA89787C2 (ru)
UY (1)	UY28955A1 (ru)
WO (1)	WO2005121161A1 (ru)
ZA (1)	ZA200608832B (ru)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW200637869A (en)	2005-01-28	2006-11-01	Chugai Pharmaceutical Co Ltd	The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
DE102005026762A1 (de)	2005-06-09	2006-12-21	Sanofi-Aventis Deutschland Gmbh	Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
PE20080251A1 (es)	2006-05-04	2008-04-25	Boehringer Ingelheim Int	Usos de inhibidores de dpp iv
BRPI0711949A2 (pt)	2006-05-19	2012-01-17	Taisho Pharmaceutical Co., Ltd.	composto c-fenil glicitol
CA2655937A1 (en)	2006-06-29	2008-01-03	Taisho Pharmaceutical Co., Ltd.	C-phenyl 1-thioglucitol compound
RU2009108280A (ru)	2006-08-08	2010-09-20	Санофи-Авентис (Fr)	Ариламиноарилалкилзамещенные имидазолидин-2,4-дионы, способы их получения, содержащие эти соединения лекарственные средства и их применение
DE102006053637B4 (de) *	2006-11-14	2011-06-30	Sanofi-Aventis Deutschland GmbH, 65929	Neue mit Fluor substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
CA2672176A1 (en)	2006-12-14	2008-06-19	Taisho Pharmaceutical Co., Ltd.	1-phenyl 1-thio-d-glucitol derivative
EP2025674A1 (de)	2007-08-15	2009-02-18	sanofi-aventis	Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
JP5272395B2 (ja) *	2007-12-12	2013-08-28	セントラル硝子株式会社	４−デオキシ−４−フルオロ−ｄ−グルコース誘導体の製造方法
EP2310372B1 (en)	2008-07-09	2012-05-23	Sanofi	Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
JP4825322B1 (ja) *	2008-08-28	2011-11-30	ファイザー・インク	ジオキサ−ビシクロ［３．２．１］オクタン−２，３，４−トリオール誘導体
WO2010068601A1 (en)	2008-12-08	2010-06-17	Sanofi-Aventis	A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
RU2518896C2 (ru)	2009-02-23	2014-06-10	Тайсо Фармасьютикал Ко., Лтд.	Производные 4-изопропилфенилглюцита в качестве ингибиторов sglt1
EP2298782A1 (en)	2009-08-26	2011-03-23	Sanofi-Aventis	Method for producing pyrazole glycoside derivatives
MX2012001729A (es)	2009-08-26	2012-06-13	Sanofi Sa	Nuevos hidratos cristalinos de fluoroglicosido heteroaromatico, productos farmaceuticos que comprenden estos compuestos, y su empleo.
KR20120091174A (ko)	2009-10-02	2012-08-17	사노피	골질환 치료제의 제조를 위한 ｓｇｌｔ-1/ｓｇｌｔ-2 억제제 활성을 갖는 화합물의 용도
US8163704B2 (en)	2009-10-20	2012-04-24	Novartis Ag	Glycoside derivatives and uses thereof
NZ599945A (en)	2009-11-02	2014-05-30	Pfizer	Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
HUE040486T2 (hu)	2009-11-13	2019-03-28	Astrazeneca Ab	Kétrétegû tabletta készítmények
SI2498759T1 (sl)	2009-11-13	2018-12-31	Astrazeneca Ab	Formulacije tablet s takojšnjim sproščanjem
CA2780938A1 (en)	2009-11-13	2011-05-19	Bristol-Myers Squibb Company	Reduced mass metformin formulations
WO2011107494A1 (de)	2010-03-03	2011-09-09	Sanofi	Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2011157827A1 (de)	2010-06-18	2011-12-22	Sanofi	Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
US8530413B2 (en)	2010-06-21	2013-09-10	Sanofi	Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en)	2010-07-05	2012-04-16	Sanofi Aventis	Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201221505A (en)	2010-07-05	2012-06-01	Sanofi Sa	Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en)	2010-07-05	2012-04-16	Sanofi Sa	(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
EP2607360B1 (en)	2010-08-20	2015-08-19	Taisho Pharmaceutical Co., Ltd.	4-Isopropyl-6-methoxyphenyl glucitol compound
US8822674B2 (en)	2010-08-20	2014-09-02	Taisho Pharmaceutical Co., Ltd	Crystal form of 4-isopropylphenyl glucitol compound and process for production thereof
CN103370064A (zh)	2010-09-03	2013-10-23	百时美施贵宝公司	使用水溶性抗氧化剂的药物制剂
EP2670397B1 (en)	2011-02-01	2020-05-13	Bristol-Myers Squibb Company	Pharmaceutical formulations including an amine compound
WO2012120058A1 (de)	2011-03-08	2012-09-13	Sanofi	Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683702B1 (de)	2011-03-08	2014-12-24	Sanofi	Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683704B1 (de)	2011-03-08	2014-12-17	Sanofi	Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683700B1 (de)	2011-03-08	2015-02-18	Sanofi	Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2766349B1 (de)	2011-03-08	2016-06-01	Sanofi	Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683703B1 (de)	2011-03-08	2015-05-27	Sanofi	Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683699B1 (de)	2011-03-08	2015-06-24	Sanofi	Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683705B1 (de)	2011-03-08	2015-04-22	Sanofi	Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8809325B2 (en)	2011-03-08	2014-08-19	Sanofi	Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof
US8614195B2 (en) *	2011-04-14	2013-12-24	Novartis Ag	Glycoside derivatives and uses thereof
AR087701A1 (es) *	2011-08-31	2014-04-09	Japan Tobacco Inc	Derivados de pirazol con actividad inhibidora de sglt1
WO2013037390A1 (en)	2011-09-12	2013-03-21	Sanofi	6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en)	2011-09-27	2013-04-04	Sanofi	6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
UA113086C2 (xx)	2012-05-10	2016-12-12		Піразольні сполуки як інгібітори sglt1
TW201425326A (zh)	2012-10-05	2014-07-01	Lilly Co Eli	新穎脲化合物
SG10201700267PA (en)	2013-02-04	2017-02-27	Taisho Pharmaceutical Co Ltd	Prophylactic or therapeutic drug for constipation
EP2774619B1 (de)	2013-03-04	2016-05-18	BioActive Food GmbH	Zusammensetzung zur Behandlung von hyperglykämischen Erkrankungen
AR098670A1 (es)	2013-11-08	2016-06-08	Lilly Co Eli	Inhibidor de sglt1
EP2944311A1 (de)	2014-05-16	2015-11-18	BioActive Food GmbH	Kombination von biologisch aktiven Substanzen zur Behandlung von hyperglykämischen Erkrankungen
JP7130588B2 (ja) *	2018-04-04	2022-09-05	日本たばこ産業株式会社	ヘテロアリールで置換されたピラゾール化合物及びその医薬用途
AU2019387370A1 (en)	2018-11-30	2021-06-10	Nuvation Bio Inc.	Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU719726B2 (en) *	1996-12-26	2000-05-18	Tanabe Seiyaku Co., Ltd.	Propiophenone derivatives and process for preparing the same
AU782330B2 (en) *	1999-08-31	2005-07-21	Kissei Pharmaceutical Co. Ltd.	Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
PH12000002657B1 (en) *	1999-10-12	2006-02-21	Bristol Myers Squibb Co	C-aryl glucoside SGLT2 inhibitors
ATE455785T1 (de) *	2000-11-02	2010-02-15	Ajinomoto Kk	Neue pyrazolderivate und diese enthaltende mittel gegen diabetes
EP1373565A2 (en) *	2001-02-14	2004-01-02	Tularik Inc.	Methods for the diagnosis and treatment of tumors employing the hepsin gene
EP1544208B1 (en) *	2002-08-08	2010-05-26	Kissei Pharmaceutical Co., Ltd.	Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
JP2004137245A (ja) *	2002-08-23	2004-05-13	Kissei Pharmaceut Co Ltd	ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体
AU2003262262A1 (en) *	2002-08-27	2004-03-19	Kissei Pharmaceutical Co., Ltd.	Pyrazole derivatives, medicinal composition containing the same, and medicinal use thereof
JP4530855B2 (ja) *	2002-10-04	2010-08-25	キッセイ薬品工業株式会社	ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体
WO2004050122A1 (ja) *	2002-12-04	2004-06-17	Kissei Pharmaceutical Co., Ltd.	高血糖症に起因する疾患の予防又は治療剤
DE10258008B4 (de) *	2002-12-12	2006-02-02	Sanofi-Aventis Deutschland Gmbh	Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
WO2004113359A1 (ja) *	2003-06-20	2004-12-29	Kissei Pharmaceutical Co., Ltd.	ピラゾール誘導体、それを含有する医薬組成物及びその製造中間体

2004
- 2004-06-11 DE DE102004028241A patent/DE102004028241B4/de not_active Expired - Fee Related
2005
- 2005-06-03 AU AU2005252329A patent/AU2005252329B2/en not_active Ceased
- 2005-06-03 DK DK05746637T patent/DK1758914T3/da active
- 2005-06-03 RU RU2007101154/04A patent/RU2370499C2/ru not_active IP Right Cessation
- 2005-06-03 BR BRPI0510770-9A patent/BRPI0510770A/pt not_active IP Right Cessation
- 2005-06-03 EP EP05746637A patent/EP1758914B1/de active Active
- 2005-06-03 RS RSP-2008/0017A patent/RS50541B/sr unknown
- 2005-06-03 CA CA2570042A patent/CA2570042C/en not_active Expired - Fee Related
- 2005-06-03 ES ES05746637T patent/ES2296180T3/es active Active
- 2005-06-03 CN CN200580019067A patent/CN100582116C/zh not_active Expired - Fee Related
- 2005-06-03 MX MXPA06013513A patent/MXPA06013513A/es active IP Right Grant
- 2005-06-03 UA UAA200700259A patent/UA89787C2/ru unknown
- 2005-06-03 DE DE502005002056T patent/DE502005002056D1/de active Active
- 2005-06-03 PT PT05746637T patent/PT1758914E/pt unknown
- 2005-06-03 JP JP2007526254A patent/JP4996464B2/ja not_active Expired - Fee Related
- 2005-06-03 WO PCT/EP2005/005959 patent/WO2005121161A1/de active Application Filing
- 2005-06-03 SI SI200530142T patent/SI1758914T1/sl unknown
- 2005-06-03 PL PL05746637T patent/PL1758914T3/pl unknown
- 2005-06-03 NZ NZ551948A patent/NZ551948A/en not_active IP Right Cessation
- 2005-06-09 MY MYPI20052616A patent/MY143565A/en unknown
- 2005-06-09 TW TW094118973A patent/TWI382030B/zh not_active IP Right Cessation
- 2005-06-10 PE PE2005000666A patent/PE20060297A1/es not_active Application Discontinuation
- 2005-06-10 UY UY28955A patent/UY28955A1/es unknown
- 2005-06-13 AR ARP050102406A patent/AR049393A1/es not_active Application Discontinuation
2006
- 2006-10-24 ZA ZA200608832A patent/ZA200608832B/en unknown
- 2006-11-27 CR CR8773A patent/CR8773A/es not_active Application Discontinuation
- 2006-11-30 IL IL179757A patent/IL179757A/en not_active IP Right Cessation
- 2006-12-05 MA MA29515A patent/MA28653B1/fr unknown
- 2006-12-06 US US11/567,410 patent/US7820804B2/en not_active Expired - Fee Related
- 2006-12-08 TN TNP2006000409A patent/TNSN06409A1/en unknown
- 2006-12-08 EC EC2006007054A patent/ECSP067054A/es unknown
2007
- 2007-01-10 NO NO20070176A patent/NO20070176L/no not_active Application Discontinuation
- 2007-07-31 HK HK07108324.3A patent/HK1100411A1/xx not_active IP Right Cessation
2008
- 2008-01-16 HR HR20080023T patent/HRP20080023T3/xx unknown
- 2008-02-04 CY CY20081100139T patent/CY1107426T1/el unknown

Also Published As

Publication number	Publication date
IL179757A (en)	2010-12-30
AR049393A1 (es)	2006-07-26
WO2005121161A1 (de)	2005-12-22
AU2005252329A1 (en)	2005-12-22
ES2296180T3 (es)	2008-04-16
RS50541B (sr)	2010-05-07
IL179757A0 (en)	2007-05-15
TNSN06409A1 (en)	2008-02-22
SI1758914T1 (sl)	2008-04-30
NZ551948A (en)	2010-04-30
DE502005002056D1 (de)	2008-01-03
DE102004028241A1 (de)	2006-01-05
CA2570042C (en)	2013-01-15
RU2007101154A (ru)	2008-07-20
US20070197623A1 (en)	2007-08-23
PT1758914E (pt)	2008-01-31
EP1758914A1 (de)	2007-03-07
BRPI0510770A (pt)	2007-11-20
MXPA06013513A (es)	2007-03-01
EP1758914B1 (de)	2007-11-21
DK1758914T3 (da)	2008-03-17
RU2370499C2 (ru)	2009-10-20
JP4996464B2 (ja)	2012-08-08
DE102004028241B4 (de)	2007-09-13
TW200610527A (en)	2006-04-01
PE20060297A1 (es)	2006-05-25
CY1107426T1 (el)	2012-12-19
CA2570042A1 (en)	2005-12-22
JP2008501745A (ja)	2008-01-24
TWI382030B (zh)	2013-01-11
CN1964984A (zh)	2007-05-16
UA89787C2 (ru)	2010-03-10
AU2005252329B2 (en)	2011-02-10
ECSP067054A (es)	2007-01-26
UY28955A1 (es)	2006-01-31
CN100582116C (zh)	2010-01-20
MA28653B1 (fr)	2007-06-01
US7820804B2 (en)	2010-10-26
NO20070176L (no)	2007-03-09
PL1758914T3 (pl)	2008-04-30
MY143565A (en)	2011-05-31
CR8773A (es)	2008-02-28
HK1100411A1 (en)	2007-09-21
HRP20080023T3 (en)	2008-06-30

Publication	Publication Date	Title
ZA200608832B (en)	2008-05-28	Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof
JP4167592B2 (ja)	2008-10-15	カルボキサミド置換フェニル尿素誘導体、及び医薬としてのそれらの製造方法
AU2003289911B2 (en)	2009-09-17	Novel fluoroglycoside heterocyclic derivatives, pharmaceutical products containing said compounds and the use thereof
ZA200503364B (en)	2006-11-29	Novel aromatic fluoroglycoside derivates, pharmaceutical products containing said compounds and the use thereof
JP4511927B2 (ja)	2010-07-28	新しいチオフェングリコシド誘導体、その製造方法、該化合物を含む医薬及びその使用
DE10139416A1 (de)	2003-03-06	Aminoalkyl substituierte aromatische Bicyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
MXPA04011984A (es)	2005-03-07	Derivados del acido n-benzoil-ureido-cinamico, procedimientos para su preparacion y su uso.
MXPA04009239A (es)	2005-01-25	Derivados de acil-3-carboxifenilurea, procedimientos para su preparacion y su utilizacion.
ZA200505762B (en)	2006-05-31	Arlycycloalkyl derivatives with branched side chains as ppar receptor modulators, method for their producion and their use as medicament
AU2003273913A1 (en)	2004-05-04	Carboxyalkoxy-substituted acyl-carboxyphenyl-urea derivatives, production method and use thereof as medicine
JPH03130255A (ja)	1991-06-04	アニリン誘導体およびそれを有効成分とする抗炎症剤
NZ540694A (en)	2007-02-23	Novel aromatic fluoroglycoside derivatives, pharmaceutical products containing said compounds and the use thereof